Cover Story

Popular GPs have the advantage in fee negotiations with potential investors in their funds because so many LPs want in, putting a premium on access.

Politicians have been setting their sights on private equity for a while, but it’s the SEC’s Gary Gensler who is likely to lead the charge and take substantive regulatory action.

Baratta's shares his New Year's resolution, books he's reading and high and low career moments, as well as his fantasy management role in the NFL.

We asked the managing director a few personal questions regarding what he does with his spare time when he's not working the private equity salt mines.

We asked the senior managing director a few personal questions regarding what she's reading, career paths and learning a new instrument.

Will dealmaking roar on or will GPs instead exercise restraint? Will vigorous fundraising continue or will LPs pull back? And how will the industry manage a full agenda of pressing issues, including everything from ESG to transparency?

For founders Kevin Ma and Ron Nayot, the evolution from independent sponsor to fund manager was eye-opening, exhausting and sometimes punishing.

This theme is being embraced by investors across the spectrum and could be a boon for payors, providers and, most importantly, patients.

Blackstone’s Tactical Opportunities strategy, hatched a decade ago by David Blitzer, is nimble, focused and all-weather. Other big-name firms are also making creative contributions to the unique asset class.

With cybercriminals constantly innovating, tech investors are assuming the worst and are looking beyond prevention to detection and rapid response.